phenyl acetate has been researched along with Abdominal Aortic Aneurysm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araújo, AC; Busch, A; Caidahl, K; Di Gennaro, A; Eriksson, P; Haeggström, JZ; Jin, H; Maegdefessel, L; Samuelsson, B; Vorkapic, E; Wågsäter, D | 1 |
Araújo, AC; Haeggström, JZ; Tang, X | 1 |
1 review(s) available for phenyl acetate and Abdominal Aortic Aneurysm
Article | Year |
---|---|
Targeting cysteinyl-leukotrienes in abdominal aortic aneurysm.
Topics: Acetates; Aortic Aneurysm, Abdominal; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Blood Vessels; Cyclopropanes; Cysteine; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Receptors, Leukotriene; Sulfides; Thrombosis | 2018 |
1 other study(ies) available for phenyl acetate and Abdominal Aortic Aneurysm
Article | Year |
---|---|
Cysteinyl leukotriene receptor 1 antagonism prevents experimental abdominal aortic aneurysm.
Topics: Acetates; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Chemokine CCL3; Cyclopropanes; Disease Models, Animal; Leukotriene Antagonists; Matrix Metalloproteinase 9; Mice; Mice, Knockout, ApoE; Quinolines; Receptors, Leukotriene; Sulfides | 2018 |